Ethical issues raised by intergenerational monitoring in clinical trials of germline gene modification - PubMed

Ethical issues raised by intergenerational monitoring in clinical trials of germline gene modification - PubMed

Ethical issues raised by intergenerational monitoring in clinical trials of germline gene modification

Austen Yeager 1

Affiliations 

• PMID: 32839228
 
• DOI: 10.1136/medethics-2020-106095

Abstract

As research involving gene editing continues to advance, we are headed in the direction of being able to modify the human germline. Should we reach a point where an argument can be made that the benefits of preventing unborn children and future generations from inheriting genetic conditions that cause tremendous suffering outweigh the risks associated with altering the human germline, the next step will be to design clinical trials using this technology in humans. These clinical trials will likely require careful follow-up and monitoring of future generations born with altered genes. This paper addresses some of the ethical issues raised by intergenerational monitoring and sets out to show that these issues can be avoided with careful consideration and clinical trial design.

Keywords: clinical trials; genethics; genetic engineering.

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Conflict of interest statement

Competing interests: None declared.

Similar articles

• Intergenerational monitoring in clinical trials of germline gene editing.

  Cwik B.J Med Ethics. 2020 Mar;46(3):183-187. doi: 10.1136/medethics-2019-105620. Epub 2019 Aug 31.PMID: 31473657 Free PMC article.
• Islamic Perspectives on CRISPR/Cas9-Mediated Human Germline Gene Editing: A Preliminary Discussion.

  Isa NM, Zulkifli NA, Man S.Sci Eng Ethics. 2020 Feb;26(1):309-323. doi: 10.1007/s11948-019-00098-z. Epub 2019 Mar 4.PMID: 30830592
• Why Human Germline Editing is More Problematic than Selecting Between Embryos: Ethically Considering Intergenerational Relationships.

  Rehmann-Sutter C.New Bioeth. 2018 Apr;24(1):9-25. doi: 10.1080/20502877.2018.1441669.PMID: 29529985
• Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.

  Vassena R, Heindryckx B, Peco R, Pennings G, Raya A, Sermon K, Veiga A.Hum Reprod Update. 2016 Jun;22(4):411-9. doi: 10.1093/humupd/dmw005. Epub 2016 Feb 29.PMID: 26932460 Review.
• The ethics of creating genetically modified children using genome editing.

  Ishii T.Curr Opin Endocrinol Diabetes Obes. 2017 Dec;24(6):418-423. doi: 10.1097/MED.0000000000000369.PMID: 28885275 Review.